'Antibodies induced by Covishield and Covaxin gradually increase and decrease'

'Antibodies remain in the blood for at least seven to nine months.' IMAGE: Vaccination on the road at Salamandra village, Margo Munda, in Deoghar, Jharkhand, December 23, 2021. Photograph: ANI......

Covid vax for kids: Mandaviya says don't want to rush

Union Health Minister Mansukh Mandaviya on Thursday said the government does not want to make haste about administering COVID-19 vaccine to children and any decision in this regard will be taken......

Should Children Get COVID-19 Vaccine?

Only half India's population has received the first shot of Covishield and Covaxin and the government's immediate task is to first vaccinate its adult population before placing its focus on......

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up......

Cadila believes it has silver bullet to fight COVID-19

Can Interferon alfa-2b treat COVID-19 effectively?Sohini Dutt reports. Kindly note the image has been posted only for representational purposes. Photograph: PTI Photo Ahmedabad-based......

MNC pharma cos may be afflicted by pneumonia virus

Aurobindo Pharma, Cadila Healthcare and Serum Institute are readying their vaccine candidates. Illustration: Uttam Ghosh/Rediff.com The duopoly of pneumonia vaccines in India is in for some......

'It was very hard to build an R&D set-up in India'

'In any organisation, a continuous line of leadership, is required.' 'All R&D will be of focus. All the way from Active Pharmaceutical Ingredients to R&D in formulations, to biologics, NCEs,......

Cadila gets USFDA nod for new diabetes molecule

Cadila Healthcare said on Thursday it has received approval from the US health regulator to carry out clinical trials of its new drug molecule, ZYGK1, aimed at treating diabetes.Approval was given......